Skip to main content

Table 3 Adverse events

From: Effects of sitagliptin beyond glycemic control: focus on quality of life

Event Number
Death (cause unknown) 1
Worsening of vomiting, stomachache, constipation 1
Loss of consciousness 1
Hypoglycemia 1
Intestinal tuberculosis, pneumonia 1
Stool abnormality 2
Acute myocardial infarction 1
Thrombocytopenia 1
Worsening of heart failure 1
New onset of dyslipidemia 3
Bleeding or ulcer of GI tract 2
Liver dysfunction 4
Elevation of CPK 2
Fever and poor physical health 1
Skin disease including eruption 2
Total number of incidents 24 in 23 subjects
  1. GI, gastric intestinal; CPK, creatinine phosphokinase.
  2. Liver dysfunction is defined as elevated (> 2.5 × the upper limit of normal) alanine aminotransferase or aspartate aminotransferase.
  3. Elevation of CPK is defined as elevated > 2 × the upper limit of normal.